January 24 (Sat.) |
08:30-08:40 |
Presidential Welcome Address |
Si Young Song
(President, KSGC) |
(Plenary Session 1.) |
Cancer and Immunity - Step on a New Paradigm of Cancer Therapy |
Chairpersons: Si Young Song (Yonsei University, Korea), Jin Tae Jung (Catholic University of Daegu, Korea) |
08:40-09:00 |
Cancer and Immunity - Overview for Finding a Way for Novel Anti Cancer Therapy |
Kyungho Choi
(Seoul National University, Korea) |
09:00-09:20 |
Current and Future's Direction of Immunologic Treatment for GI Cancer |
Tae-ho Hwang
(Pusan National University, Korea)
|
09:20-09:40 |
Current Trends of Chimeric Antigen Receptor (CAR) Therapy for GI Cancel |
Sungyoo Cho
(Green Cross LabCell, Korea)
|
09:40-09:50 |
Q & A |
|
09:50-10:10 |
Coffee break |
|
(Clinical Symposia 1.) |
Emerging Issue: Optimal Cancer Care in Aging Population |
Chairpersons: Ho Soon Choi (Hanyang University, Korea), Yoon Jung Lim (Dongguk University, Korea) |
10:10-10:30 |
Specific Issues in Chemotherapy and Its Toxicity for Elderly Patients |
In Sil Choi
(Seoul National University, Korea) |
10:30-10:50 |
Specific Problems in Surgery for Elderly Patients |
Kok-Yang Tan
(Khoo Teck Puat Hospital, Singapore) |
10:50-11:10 |
The Meaning of Geriatric Assessment in the Older with GI Cancer |
Chang Oh Kim
(Yonsei University, Korea)
|
11:10-11:20 |
Q & A |
|
(Translational Symposia 1.) |
Road to Deliver Clinical Benefit from Genomic Research for GI Cancer Management |
Chairpersons: Hoon Jai Chun (Korea University, Korea), Soonmyung Paik (Yonsei University, Korea) |
11:20-11:40 |
NGS Platform and the Genomics Technology Trends |
Jong Bhak
(UNIST, Korea)
|
11:40-12:00 |
Best Handling Techniques of NGS Data - Recent Progress of Bioinformatic Software |
Sangsoo Kim
(Soongsil University, Korea)
|
12:00-12:20 |
Strategies to Successful Implementation of Tailored Therapy with Genomic Profiling for GI Cancer |
Soonmyung Paik
(Yonsei University, Korea)
|
12:20-12:30 |
Q & A¡¡ |
|
(Lunch break) |
Chairpersons: Jae Kwang Kim (The Catholic University of Korea, Korea), Hong Sik Lee (Korea University, Korea) |
12:30-13:00 |
Luncheon Symposium 1. Beyond Trastuzumab for HER2(+) Patients in Gastric Cancer¡¡ |
Yongzhe Piao
(Roche Product Development in Asia Pacific, China) |
13:00-13:30 |
Luncheon Symposium 2. Luncheon Symposium 2. A New erea for Cancer Vaccines: Filling the Void Where Checkpoint Inhibitors Fail to Work Due to Lack of Spontaneous Immune Responses |
Gustav Gaudernack
(Oslo University Hospital - Radiumhospitalet , Norway) |
(Plenary Session 2.) |
Quality of Life for GI Cancer Patients - Nutririon and Pain |
Chairpersons: Young Woo Choi (Konyang University, Korea), Kwang Ro Joo (Kyung Hee University, Korea), Jose D. Sollano (University of Santo Tomas, Philippines) |
13:30-13:50 |
Our Effort to Call the Attention for Importance of Nutritional Intervetion for GI Cancer |
Geun Am Song
(Pusan National University, Korea)
|
13:50-14:10 |
Nutritional Screening and Assessment Registry in Korean Gastroenterointestinal Cancer Patients |
Eun Sun Kim
(Korea University, Korea)
|
14:10-14:30 |
General Public Awareness of Digestive Cancer Disease in Korea |
Sang-Woo Cha
(Soonchunhyang University, Korea)
|
14:30-14:40 |
Q & A¡¡ |
|
(Clinical Symposia 2.) |
Gastroenteropancreatic Neuroendocrine Tumors |
Chairpersons: Myung Hwan Noh (Dong-A University, Korea), Woo Jin Lee (National Cancer Center, Korea) |
14:40-15:00 |
Role of Gastroenterologists/endoscopists for GEP-NET |
Hsiu-Po Wang
(National Taiwan University Hospital, Taiwan)
|
15:00-15:20 |
Tumor Control & Symptom Control in NET Patients with Somatostatin Analogue |
Chen Jie
(The First Affiliated Hospital of Sun Yat-Sen University , China)
|
15:20-15:40 |
Efficacy and Toxicity of Peptide Receptor Targeted Radiopeptide Therapy in NET |
Sunju Choi
(Korea Atomic Energy Research Institute, Korea)
|
15:40-15:50 |
Q & A¡¡ |
|
15:50-16:10 |
Coffee Break |
|
(Clinical Symposia 3.) |
Endoscopy and New Strategies for GI Cancer |
Chairpersons: Hyun Yong Jeong (Chungnam National University, Korea), Sang Kil Lee (Yonsei University, Korea), Varocha Mahachai (Bangkok Medical Center, Thailand) |
16:10-16:30 |
Beyond Interventional Endoscopic Treatment of Gastric and Esophageal Cancer |
Joo Young Cho
(CHA University, Korea)
|
16:30-16:50 |
Endoscopic Biopsies from the Gastrointestinal Tract and Their Suitability for Molecular Analyses |
Heike I Grabsch
(Maastricht University Medical Center, The Netherlands)
|
16:50-17:10 |
Updating Advances and Controversies on Neoadjuvat Therapy of Gastric Cancer |
Hee Seok Moon
(Chungnam National University, Korea)
|
17:10-17:30 |
Targeted Therapies for Esophageal and Gastric Cancers |
Thomas Yau
(The University of Hong Kong, Hong Kong)
|
17:30-17:40 |
Q & A¡¡ |
|
January 25 (Sun.) |
(Translational Symposia 2.) |
Current and Future of Anticancer Drug - Voice from Pharmaceutical Companies |
Chairpersons: Seung Woo Park (Yonsei University, Korea), Sung-Vin Yim (Kyung Hee University, Korea) |
08:00-08:15 |
Discovery and Development of CG200745, a Highly Potent HDAC Inhibitor: An Experience from Protein Structure to Clinic |
Seonggu Ro
(CrystalGenomics, Korea)
|
08:15-08:30 |
JW Group: An Overview of Recent Development of Anti-Cancer Drug |
Kyoung June Lee
(JW Pharmaceutical, Korea)
|
08:30-08:45 |
Current Clinical Anticancer Agents of Hanmi and Their Scientific Backgrounds for Discovery and Development
|
Young-Mi Lee
(Hanmi Pharmceutical, Korea)
|
08:45-08:55 |
Q & A |
|
(Free Paper Session I) |
|
Chairpersons: Sung Soo Kim (The Catholic University of Korea, Korea), Moo In Park (Kosin University, Korea) |
08:55-09:05 |
Neoadjuvant Cytotoxic Chemotherapy Has No Effect on Intratumoural Vascularity but Increases Intratumoural Immune Cell Infiltration - Results from a Pilot Study in Oesophageal Cancer |
Alexander J Blayney
(University of Leeds, UK)
|
09:05-09:15 |
Long-term outcome of Minimally Invasive Treatment of Early Gastric Cancer beyond Endoscopic Submucosal Dissection |
Weon Jin Ko
(CHA Univeristy, Korea)
|
09:15-09:25 |
MHY218-Induced Apoptotic Cell death is Mediated by Iinhibition of Autophagy in AGS Human Gastric Cancer Cells |
Jae Hyun Kim
(Kosin University, Korea)
|
09:25-09:35 |
Amplification of EGFR, ERBB2 and FGFR2 is associated with a Decrease in Tumour Infiltrating Immune Cells in Japanese Stage II/III Gastric Cancers |
Arnaldo Neves Santos Silva
(University of Leeds, UK)
|
09:35-09:45 |
Decreasing Trend of Gastric Cancer and Helicobacter Pylori Infection in the Philippines: A 10-year Observational Study |
Karen Estelle de Luna
(University of Santo Tomas Hospital, Philippines)
|
09:45-09:55 |
The Therapeutic Effect of Irreversible Electroporation in Gastrointestinal Cancer Animal Model |
Hyuk Soon Choi
(Korea University, Korea)
|
(Free Paper Session II) |
|
Chairpersons: Bora Keum (Korea University, Korea), Il Hyun Baek (Kyung Hee University, Korea) |
09:55-10:05 |
NGS Platform and the Genomics Technology Trends |
Kwang Hyun Chung
(Seoul National Univeristy, Korea)
|
10:05-10:15 |
Best Handling Techniques of NGS Data - Recent Progress of Bioinformatic Software |
Chan Young Jang
(Yonsei University, Korea)
|
10:15-10:25 |
Strategies to Successful Implementation of Tailored Therapy with Genomic Profiling for GI Cancer |
Sung Yong Han
(Pusan National University, Korea)
|
10:25-10:35 |
Down-regulation of TAGLN2 Suppresses Biliary Cancer Tumor Growth via C-met/akt/nanog pathway |
Sang Hoon Lee
(Yonsei University, Korea)
|
10:35-10:55 |
Coffee Break |
|
(Plenary Session 3.) |
Surging the Wave of Big Data for Cancer Prevention and Treatment (Korean Session) |
Chairpersons: Yong Tae Kim (Seoul National University, Korea), Jin Seok Jang (Dong-A University, Korea) |
10:55-11:15 |
Current Status of Big Data in Korea : Overview |
Sangwon Lee
(Korea Health Industry Development Institute, Korea)
|
11:15-11:35 |
Role of National Evidence-Based Healthcare Collaboration Agency (NECA) for Use of Big Data in Medical Research in Korea |
Tae-Hwan Lim
(National Evidence-based Healthcare Collaborating Agency, Korea)
|
11:35-11:55 |
How to Use Big Data to Improved Cancer Treatment |
Log-young Kim
(Health Insurance Review and Assessment Service, Korea)
|
11:55-12:05 |
Q & A |
|
(Lunch break) |
Chairperson: Chang Hun Yang (Dongguk University, Korea) |
12:05-13:15 |
Luncheon Symposium 3. Advances of Chemotherapy for Metastatic Colorectal Cancer¡¡ |
Eishi Baba
(Kyushu University, Japan) |
(Clinical Symposia 4.) |
Current and Evolving Issues in Colorectal Cancer |
Chairpersons: Geun Am Song (Pusan National University, Korea), Seun Ja Park (Kosin University, Korea), Abdullah Murdani (University of Indonesia, Dr. Cipto Mangunkusumo Hospital, Indonesia) |
13:15-13:35 |
Recent Advances in Colorectal Carcinogenesis: Serrated Pathway and Interval Cancer |
Byung Ik Jang
(Yeungnam University, Korea)
|
13:35-13:55 |
Endoscopy-oriented Therapeutic Strategy in Early Colorectal Cancer |
Bong Min Ko
(Soonchunhyang University, Korea)
|
13:55-14:15 |
Recent Update in Minimally Invasive Surgery for Colorectal Cancer |
Gyu-Seog Choi
(Kyungpook National Universiy, Korea)
|
14:15-14:35 |
Biomarker-directed Targeted Therapy in Colorectal Cancer |
John Michael Carethers
(University of Michigan, USA)
|
14:35-14:45 |
Q & A |
|
14:45-15:05 |
Coffee Break |
|
(Clinical Symposia 5.) |
Current Status and Future Strategies in Managing for Pancreatic Cancer |
Chairpersons: Ho Gak Kim (Catholic University of Daegu, Korea), Ji Kon Ryu (Seoul National University, Korea) |
15:05-15:25 |
Surgical Perspective on Early Pancreatic Cancer |
Yoo-Seok Yoon
(Seoul National University, Korea)
|
15:25-15:45 |
Neoadjuvant Treatment for Borderline or Locally Advanced Pancreatic Cancer |
Woo Jin Lee
(National Cancer Center, Korea)
|
15:45-16:05 |
Molecular Targeted and/or Chemotherapy for Far Advanced Pancreatic Cancer |
Seungmin Bang
(Yonsei University, Korea)
|
16:05-16:15 |
Q & A |
|
16:30-17:00 |
Poster Round¡¡ |
|